A detailed history of B Group, Inc. transactions in Insmed Inc stock. As of the latest transaction made, B Group, Inc. holds 350,000 shares of INSM stock, worth $28.5 Million. This represents 14.77% of its overall portfolio holdings.

Number of Shares
350,000
Holding current value
$28.5 Million
% of portfolio
14.77%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$66.29 - $76.63 $23.2 Million - $26.8 Million
350,000 New
350,000 $24.2 Billion

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $11B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track B Group, Inc. Portfolio

Follow B Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on B Group, Inc. with notifications on news.